BioNTech RNA Pharmaceuticals GmbH;TRON - Translationale Onkologie an der Universitatsmedizin der Johannes Gutenberg-Universitat Mainz gemeinnutzige GmbH
发明人:
Sahin, Ugur,Tadmor, Arbel David,Castle, John Christopher,Boegel, Sebastian,Lower, Martin
申请号：
AU2019275637
公开号：
AU2019275637A1
申请日:
2019.12.06
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
#$%^&*AU2019275637A120200102.pdf#####ABSTRACT The present invention relates to methods for predicting T cell epitopes. In particular, the present invention relates to methods for predicting whether modifications in peptides or polypeptides such as tumor-associated neoantigens are immunogenic or not. The methods of the invention are useful, in particular, for the provision of vaccines which are specific for a patient's tumor and, thus, in the context of personalized cancer vaccines.
